SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-096600
Filing Date
2016-04-27
Accepted
2016-04-27 16:05:22
Documents
2
Period of Report
2016-04-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v438008_8k.htm 8-K 15663
2 EXHIBIT 10.1 v438008_ex10-1.htm EX-10.1 38035
  Complete submission text file 0001144204-16-096600.txt   54963
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Filer) CIK: 0001327467 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36179 | Film No.: 161595357
SIC: 2834 Pharmaceutical Preparations